RECORD PREVIEW · FIELD RECORD ×2BOUNDED — REAL RELEASED DATA
CLAIM · CLM-2ba8180839ffac57GRADE VERY_LOW
amla — antioxidant
direction BENEFIT · dose 10 mg/kg; 35 g; 400 g; 500 mg; 65 mg/kg · duration 18 week; 42 days; 6 months
Grade basis — weakest-link ceilings
HIGHdesign
LOWdirectness
LOWextraction
VERY_LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
10bound studies
Bound studies (4 shown of 10)
STU-0f41bcecbc072239ANIMAL · ANIMAL · 2007 · RoB INSUFFICIENT_INFORMATION
5 endpoints
STU-11fe2274ae8852ecANIMAL · ANIMAL · 2024 · RoB INSUFFICIENT_INFORMATION
4 endpoints
STU-2889d0fbc8405e76ANIMAL · ANIMAL · 2022 · RoB INSUFFICIENT_INFORMATION
1 endpoints
STU-48fb0cb1f2915860ANIMAL · ANIMAL · 2026 · RoB SOME_CONCERNS
5 endpoints
Quantitative observations
observation 500 mg · validated
observation 6 months · failed extraction
observation 65 mg/kg · validated
Opposition screen
SCREEN · 23 candidates considered · 3 bound as opposing
SYNTHESIS SYN-c6babce4cbc6fa — outcome QUALITATIVE_ONLY · BENEFIT ×10 · not_assessed_quantitatively · 10 members
PROVENANCE → crf:10.1017/s0007114507691971, epmc:PPR948586, epmc:35326136 · PKG 5b3ba0a716fd34a9…
CLAIM · CLM-e2a65e7570443af2GRADE VERY_LOW
amla constituents — antioxidant
direction BENEFIT · dose 100 mg/kg · duration 3 months; 6 weeks
Grade basis — weakest-link ceilings
VERY_LOWdesign
LOWdirectness
LOWextraction
VERY_LOWconfidence
MODERATEmethodology
HIGHconsistency
MODERATEnumeric
7bound studies
Bound studies (4 shown of 7)
STU-0b4770825788430dIN_VITRO · IN_VITRO · 2021 · RoB INSUFFICIENT_INFORMATION
1 endpoints
STU-0cc61d15c373cbe3ANIMAL · ANIMAL · 2016 · RoB INSUFFICIENT_INFORMATION
1 endpoints
STU-41f50fcf5b2f55c6IN_VITRO · IN_VITRO · 2018 · RoB INSUFFICIENT_INFORMATION
2 endpoints
STU-4fa37ea60e1c8b2dANIMAL · ANIMAL · 2007 · RoB INSUFFICIENT_INFORMATION
4 endpoints
Quantitative observations
observation p=0.05 | p=0.005 | p=0.05 · failed extraction
observation p=0.05 · validated
observation 3 months · failed extraction
Opposition screen
SCREEN · 23 candidates considered · 3 bound as opposing
SYNTHESIS SYN-2fb721e4a099b5 — outcome QUALITATIVE_ONLY · BENEFIT ×7 · not_assessed_quantitatively · 7 members
PROVENANCE → epmc:35017964, crf:10.1155/2016/1735841, oax:https://openalex.org/W2885228946 · PKG 5b3ba0a716fd34a9…
Bounded preview — representative records only. The full release ships 30 claims and 106 observations.